Research Article
Intake of Novel Red Clover Supplementation for 12 Weeks Improves Bone Status in Healthy Menopausal Women
Table 5
Inflammatory markers before (week 0) and after (week 12) the intervention in the two groups, RC and placebo.
| | RC | Placebo | | Week 0 | Week 12 | valuea | Week 0 | Week 12 | valuea |
| IL-1b, pg/mL | 16.8 (±0.9) | 16.6 (±0.9) | | 18.3 (±1.2) | 15.9 (±1.1) | | IL-2, pg/mL | 93.9 (±3.7) | 93.4 (±4.2) | | 103.3 (±5.7) | 94.9 (±6.6) | | IL-4, pg/mL | 13.5 (±0.7) | 13.3 (±0.7) | | 15.2 (±0.9) | 13.4 (±1.0) | | IL-5, pg/mL | 101.1 (±6.8) | 107.5 (±6.8) | | 104.4 (±7.9) | 97.4 (±8.0) | | IL-6, pg/mL | 21.5 (±0.9) | 22.54 (±1.2) | | 25.0 (±1.6) | 23.2 (±1.6) | | IL-10, pg/mL | 18.4 (±0.9) | 17.4 (±0.8) | | 19.6 (±1.0) | 18.1 (±1.1) | | IL-12, pg/mL | 18.8 (±0.9) | 18.0 (±0.9) | | 20.5 (±1.1) | 18.5 (±1.3) | | IL-13, pg/mL | 15.5 (±0.9) | 16.0 (±0.9) | | 17.2 (±1.1) | 15.5 (±1.1) | | IFN-gamma, pg/mL | 33.1 (±1.6) | 32.3 (±1.6) | | 35.5 (±1.8) | 35.1 (±2.1) | |
|
|
Representing value within-group differences between week 0 and week 12. Data are presented as mean (±SEM).
|